Hutajulu et al.83 found that combined analyses of five methylation markers (i.e., RASSF1A, p16, WIF1, CHFR, RIZ1) provided good discrimination between NPC and non-NPC patients with a detection rate of 98%. Here, PRDM2 is linked to nasopharyngeal carcinoma.